CDC panel: Frontline workers, 75-plus seniors should get Covid shots next
The recommendations came after spirited debate about whether more seniors should be next in line.
A nursing home resident receives a coronavirus vaccine Dec. 18 in West Hartford, Conn. | AP Photo/Stephen Dunn, Poo
Link Copied
People 75 and older and essential frontline workers should be the next in line for limited supplies of Covid-19 vaccines, an expert group advising the Centers for Disease Control and Prevention recommended Sunday.
The panel, the Advisory Committee on Immunization Practices, approved the recommendations on a 13-1 vote after robust debate about whether more seniors and high-risk groups should be given priority over some essential workers.
to PanCAN.
Anne-Marie is a senior executive with extensive experience in the biopharmaceutical industry. In her most recent role as executive vice president and chief medical officer at Rigel Pharmaceuticals, she led the development of new drugs for auto-immune diseases and was responsible for getting their first drug approved.
Anne-Marie has lost several friends to pancreatic cancer and another is currently battling the disease. She looks forward to bringing her expertise to large-scale, life-changing initiatives like PanCAN’s Precision Promise℠ to improve treatment options for pancreatic cancer patients.
Here, we share more about Anne-Marie’s background, interests and what brought her to PanCAN.
The Pancreatic Cancer Action Network (PanCAN) Welcomes New Leadership With The Appointment Of A New Board Member And The Hiring Of A Chief Medical Officer
Strategic Leadership Comes as Awareness and Momentum Around Pancreatic Cancer is Increasing Following a Succesful Pancreatic Cancer Awareness Month in November
News provided by
Share this article
LOS ANGELES, Dec. 10, 2020 /PRNewswire/ The
Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, has appointed Rodney Williams as the newest member of its board of directors (BOD) and hired Anne-Marie Duliege, M.D. as the organization s new chief medical officer (CMO). These leadership updates bring new energy and expertise to the national organization whose bold action is leading the way to accelerate progress for pancreatic cancer patients and create a world in which all pancreatic cancer patients will thrive.